Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zanetti, A
Right arrow Articles by Dejana, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zanetti, A
Right arrow Articles by Dejana, E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Clustering of vitronectin and RGD peptides on microspheres leads to engagement of integrins on the luminal aspect of endothelial cell membrane

A Zanetti, G Conforti, S Hess, I Martin-Padura, E Ghibaudi, KT Preissner and E Dejana

Instituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

In previous work (Conforti et al, Blood 80:437, 1992), we have shown that integrins in endothelial cells (EC) are not polarized to the basal cell membrane, but are also exposed on the apical cell surface, in contact with blood. Therefore, endothelial integrins might be available for binding circulating plasma proteins. However soluble plasma vitronectin (vn) bound very poorly to EC apical surface and this interaction was unaffected by Arg-Gly-Asp (RGD) peptides or an anti- alpha v beta 3 serum. In contrast, beads (diameter, 4.5 microns) coupled with plasma vn associated to EC apical surface in a time- and concentration-dependent way. Addition of antibodies directed to vn, alpha v beta 3, and RGD-containing peptides blocked the interaction of vn beads with EC. In contrast, heparin and antibodies directed to alpha v beta 5 and beta 1 integrin chain had no effect. Beads coupled with Gly-Arg-Gly-Asp-Ser-Pro bound to the EC surface, but not those coupled with Gly-Arg-Gly-Glu-Ser-Pro. This interaction was blocked by alpha v beta 3 antibodies and RGD peptides, but not by alpha v beta 5 antibody. Overall, these results indicate that luminal alpha v beta 3 retains its binding capacity for surface-linked vn and RGD-containing ligands, but binding is observed only when the ligand is offered in a clustered, multivalent form. We propose that when vn or RGD-containing proteins are bound to circulating cells, they can act as bridging molecules by promoting adhesion of the cells to the endothelium via apical integrins.

Volume 84, Issue 4, pp. 1116-1123, 08/15/1994
Copyright © 1994 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
M. R. Schroeter, M. Leifheit, P. Sudholt, N.-M. Heida, C. Dellas, I. Rohm, F. Alves, M. Zientkowska, S. Rafail, M. Puls, et al.
Leptin Enhances the Recruitment of Endothelial Progenitor Cells Into Neointimal Lesions After Vascular Injury by Promoting Integrin-Mediated Adhesion
Circ. Res., August 29, 2008; 103(5): 536 - 544.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. W. Smith, P. Marra, and C. J. Marshall
uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180
J. Cell Biol., August 25, 2008; 182(4): 777 - 790.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Buzza, L. Zamurs, J. Sun, C. H. Bird, A. I. Smith, J. A. Trapani, C. J. Froelich, E. C. Nice, and P. I. Bird
Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and Laminin
J. Biol. Chem., June 24, 2005; 280(25): 23549 - 23558.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Magnussen, I. M. Kasman, S. Norberg, P. Baluk, R. Murray, and D. M. McDonald
Rapid Access of Antibodies to {alpha}5{beta}1 Integrin Overexpressed on the Luminal Surface of Tumor Blood Vessels
Cancer Res., April 1, 2005; 65(7): 2712 - 2721.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. H. Minor and C. B. Peterson
Plasminogen Activator Inhibitor Type 1 Promotes the Self-association of Vitronectin into Complexes Exhibiting Altered Incorporation into the Extracellular Matrix
J. Biol. Chem., March 15, 2002; 277(12): 10337 - 10345.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. H. Tam, P. M. Sassoli, R. E. Jordan, and M. T. Nakada
Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and {alpha}vß3 Integrins
Circulation, September 15, 1998; 98(11): 1085 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. A. Sobel, J. R. Hinojoza, A. Maeda, and M. Chen
Endothelial Cell Integrin Laminin Receptor Expression in Multiple Sclerosis Lesions
Am. J. Pathol., August 1, 1998; 153(2): 405 - 415.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Gawaz, F.-J. Neumann, T. Dickfeld, A. Reininger, H. Adelsberger, A. Gebhardt, and A. Schomig
Vitronectin Receptor ({alpha}vß3) Mediates Platelet Adhesion to the Luminal Aspect of Endothelial Cells : Implications for Reperfusion in Acute Myocardial Infarction
Circulation, September 16, 1997; 96(6): 1809 - 1818.
[Abstract] [Full Text]


Home page
JCBHome page
H. Kashiwagi, M. A. Schwartz, M. Eigenthaler, K.A. Davis, M. H. Ginsberg, and S. J. Shattil
Affinity Modulation of Platelet Integrin alpha IIbbeta 3 by beta 3-Endonexin, a Selective Binding Partner of the beta 3 Integrin Cytoplasmic Tail
J. Cell Biol., June 16, 1997; 137(6): 1433 - 1443.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Seiffert and D. Seiffert
The Glycosaminoglycan Binding Site Governs Ligand Binding to the Somatomedin B Domain of Vitronectin
J. Biol. Chem., April 11, 1997; 272(15): 9971 - 9978.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Suehiro, J. Gailit, and E. F. Plow
Fibrinogen Is a Ligand for Integrin alpha 5beta 1 on Endothelial Cells
J. Biol. Chem., February 21, 1997; 272(8): 5360 - 5366.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. M. Odrljin, C. W. Francis, L. A. Sporn, L. A. Bunce, V. J. Marder, and P. J. Simpson-Haidaris
Heparin-Binding Domain of Fibrin Mediates Its Binding to Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1544 - 1551.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Seiffert and D. J. Loskutoff
Type 1Plasminogen Activator Inhibitor Induces Multimerization of Plasma Vitronectin. A SUGGESTED MECHANISM FOR THE GENERATION OF THE TISSUE FORM OF VITRONECTIN IN VIVO
J. Biol. Chem., November 22, 1996; 271(47): 29644 - 29651.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Zhuang, M. N. Blackburn, and C. B. Peterson
Characterization of the Denaturation and Renaturation of Human Plasma Vitronectin. I. BIOPHYSICAL CHARACTERIZATION OF PROTEIN UNFOLDING AND MULTIMERIZATION
J. Biol. Chem., June 14, 1996; 271(24): 14323 - 14332.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bhattacharya, C. Fu, J. Bhattacharya, and S. Greenberg
Soluble Ligands of the [IMAGE][IMAGE][IMAGE][IMAGE] Integrin Mediate Enhanced Tyrosine Phosphorylation of Multiple Proteins in Adherent Bovine Pulmonary Artery Endothelial Cells
J. Biol. Chem., July 14, 1995; 270(28): 16781 - 16787.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1994 by American Society of Hematology         Online ISSN: 1528-0020